Role of structural MRI in Alzheimer's disease

  • Vemuri P
  • Jack C
  • Jack C
 et al. 
  • 25


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Atrophy measured on structural magnetic resonance imaging (sMRI) is a powerful biomarker of the stage and intensity of the neurodegenerative aspect of Alzheimer's disease (AD) pathology. In this review, we will discuss the role of sMRI as an AD biomarker by summarizing (a) the most commonly used methods to extract information from sMRI images, (b) the different roles in which sMRI can be used as an AD biomarker, and (c) comparisons of sMRI with other major AD biomarkers.

Author-supplied keywords

  • Geriatrics/Gerontology
  • Neurology
  • Neurosciences

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Prashanthi Vemuri

  • Clifford R Jack

  • CR Jack

  • VJ Lowe

  • SD Weigand

  • HJ Wiste

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free